On Wednesday, WhiteWave Foods Co (NYSE:WWAV)’s shares declined -3.63% to $46.49.
The WhiteWave Foods Company ( WWAV ) stated record results for the second quarter ended June 30, 2015.
Net sales for second quarter 2015 were $924 million, a 10 percent enhance from net sales of $838 million in second quarter 2014. These results were driven by strong growth across the Americas Foods & Beverages and Europe Foods & Beverages segments and a benefit from the inclusion of So Delicious Dairy Free ® that was attained in fourth quarter 2014. On a constant currency basis, net sales raised 14 percent in second quarter 2015 over the same period in 2014. Not taking into account acquisitions, organic constant currency net sales raised 9 percent in second quarter 2015 over the same period in 2014.
Adjusted operating income for second quarter 2015 raised 20 percent to $85 million, contrast to $71 million in second quarter 2014. On a constant currency basis, adjusted operating income raised 24 percent in second quarter 2015 over the same period in 2014.
The WhiteWave Foods Company, a consumer packaged food and beverage company, manufactures, markets, distributes, and sells branded plant-based foods and beverages, salads, fruits and vegetables, coffee creamers and beverages, and dairy products and organic produce in North America and Europe. It operates in three segments: Americas Foods & Beverages, Americas Fresh Foods, and Europe Foods & Beverages.
La-Z-Boy Incorporated (NYSE:LZB)’s shares gained 2.24% to $27.79.
Directors of La-Z-Boy Incorporated (LZB) declared a quarterly cash dividend on the company’s common stock of $0.08 per share. The dividend is payable September 10, 2015 to shareholders of record as of August 31, 2015.
La-Z-Boy Incorporated manufactures, markets, imports, distributes, and retails upholstery furniture products, accessories, and casegoods furniture products in the United States, Canada, and internationally. The company also produces reclining chairs; and manufactures and distributes residential furniture in the United States. It operates in three segments: Upholstery, Casegoods, and Retail.
At the end of Wednesday’s trade, PDC Energy Inc (NASDAQ:PDCE)‘s shares dipped -4.09% to $53.66.
PDC Energy, Inc.(PDCE) stated its 2015 second quarter financial and operating results and updated its 2015 full-year guidance.
2015 Second Quarter Highlights
- Production of 37,001 Boe per day; 46% enhance year-over-year and 15% growth contrast to the first quarter of 2015.
- Crude oil production of 17,378 Bbls per day; 47% enhance year-over-year and 20% growth contrast to the first quarter of 2015.
- Spud 43 and turned-in-line 44 gross operated horizontal wells.
- In July 2015, Moody’s and Standard & Poor’s upgraded PDC’s corporate debt rating to B1 and B+ respectively, reflecting stronger operational and debt metrics.
2015 Updated Guidance Highlights
- Raised total production to a range of 14.7 to 15.0 MMBoe, compriseing of 47% oil production and an predictable year-end exit rate of greater than 48,000 Boe per day. The midpoint of the updated range is a 60% enhance from 2014 ongoing operations.
- Improved drilling efficiencies, resulting in an approximate 30% enhance in predictable wells spud to about 155 with an estimated 125 turn-in-lines.
PDC Energy, Inc., an independent exploration and production company, acquires, explores for, develops, and produces crude oil, natural gas, and natural gas liquids in the United States. The company operates in two segments: Oil and Gas Exploration and Production, and Gas Marketing. The Oil and Gas Exploration and Production segment produces and sells natural gas to midstream service providers, marketers, and utilities; crude oil; and natural gas liquids.
Sigma-Aldrich Corporation (NASDAQ:SIAL), ended its Wednesday’s trading session with -0.06% loss, and closed at $139.62.
Aldrich Corporation (NASDAQ: SIAL) declared it has secured unconditional approval from Brazil’s Council for Economic Defense (CADE), the final outstanding approval required for the planned acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany (the “Transaction”). This clearance, which will be effective after a waiting period of 15 days, follows recently received antitrust approvals from the competition authorities of Israel (IAA) and South Korea (KFTC).
On September 22, 2014, Merck and Sigma-Aldrich declared they had reached a definitive agreement under which Merck, will acquire Sigma-Aldrich for $17 billion - $140 cash per share, establishing one of the leading players in the $130 billion global life science industry.
Sigma-Aldrich Corporation, a life science and high technology company, develops, manufactures, purchases, and distributes various chemicals, biochemicals, and equipment products worldwide. The company provides chemical products, reagents, and kits and services are used in scientific research, counting genomic and proteomic research, biotechnology, pharmaceutical development, and diagnosis of disease; and as key components in pharmaceutical, diagnostics, and high technology manufacturing. It offers media and critical raw materials for industrial cell culture, contract manufacturing services, pharmaceutical safety testing services, and organometallic precursors for semiconductor manufacturing.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
